France Next-Generation Cancer Diagnostics Market Insights, Industry Trend, Forecasts to 2035

The France Next-Generation Cancer Diagnostics Market Size is the sector that revolves around the use of advanced diagnostic technologies primarily aimed at the early detection, classification, and monitoring of cancer in France. The technologies are mainly based on next-generation sequencing (NGS), molecular diagnostics, liquid biopsy, and advanced genomic and proteomic analysis. The market is a service to personalized and precision oncology by providing the means for the exact identification of genetic mutations, biomarkers, and tumor characteristics throughout hospitals, diagnostic laboratories, research institutes, and oncology centers in France.